HomeUS & Canada NewsFDA announces plan for folinic acid to be accessible prescription treatment for...

FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

Food and Drug Administration Commissioner Dr. Martin A. Makary announced that the FDA is filing a federal register notice to change the label on Leucovorin, so it can be prescribed to treat children with autism.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img